This project is to build a Good Manufacturing Practices (GMP) facility to manufacture lipids, conduct lipid nanoparticle (LNP) formulation and expand the company's existing vaccine manufacturing capac...
Northern RNA Inc.
7 records totalling $33,625,700.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| Innovation, Science and Economic Development Canada | $21,037,700 | 2 records |
| National Research Council Canada | $7,588,000 | 4 records |
| Prairies Economic Development Canada | $5,000,000 | 1 record |
Records
The COVID-19 pandemic has impacted the global supply of nucleic acid products including mRNA and plasmid DNA and delivery vehicles such as lipid nanoparticles which have been demonstrated to be import...
Establish oligonucleotide manufacturing, and self-amplifying RNA (saRNA) manufacturing capabilities.
Establish contract manufacturing facility for vaccines and lipids in Western Canada
“As part of the international consortium project “H5Nx Vaccine: Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles”, this project proposes to develop a groundbreak...
Northern RNA is developing GMP manufacturing of mRNA and DNA based vaccines at our Calgary, Alberta based facility. GMP certification requires the development and documentation of all processes relat...
The firm is aiming to develop lab methodologies that are applicable for oligonucleotide separation and its purification. These methods will be applicable depending on the length of the oligonucleotide...